Table 2.
Characteristics and Outcome of Patients Who Developed Primary GF
| Disease | Graft Type | Donor | Prior HCT | DRI | Conditioning | Outcome |
|---|---|---|---|---|---|---|
| Mycosis fungoides | Cryopreserved | HLA-matched unrelated | Yes | High | RIC (Flu/TBI) | Autologous reconstitution; alive |
| High-risk MDS > AML | Cryopreserved | HLA-matched unrelated | No | High | RIC (Flu/Mel) | Died |
| AML | Cryopreserved | HLA-matched unrelated | No | Int | RIC (Flu/Mel) | Underwent second HCT with fresh allografts; alive |
| CML | Cryopreserved | HLA-matched unrelated | No | Low | RIC (Flu/Mel) | Underwent second HCT with fresh allografts; alive |
| MDS/CMML | Fresh | Haploidentical | No | High | MAC (Bu/Cy) | Underwent second HCT; died |
MDS indicates myelodysplastic syndrome; AML, acute myelogenous leukemia; Int, intermediate; CML, chronic myelogenous leukemia; CMML, chronic myelomonocytic leukemia.